Alicia Morgans, MD, MPH

Alicia Morgans, MD, MPH, of Dana-Farber Cancer Institute

Articles by Alicia Morgans, MD, MPH

Christopher Wallis, MD, PhD, FRCSCProstate Cancer | June 24, 2025
The panel concludes with a candid discussion about the most urgent changes that could improve cancer care today.
View More
Christopher Wallis, MD, PhD, FRCSCProstate Cancer | June 24, 2025
The panel explores the importance of introducing palliative care discussions earlier in the treatment journey.
Christopher Wallis, MD, PhD, FRCSCProstate Cancer | June 24, 2025
The panel explores the overlooked burden of financial toxicity and proactively raising the topic with patients.
Christopher Wallis, MD, PhD, FRCSCProstate Cancer | June 24, 2025
The panel explores how clinicians can build trust with patients from diverse backgrounds and ensure care is patient-centered.
Christopher Wallis, MD, PhD, FRCSCProstate Cancer | June 24, 2025
The panel explores how clinicians can introduce clinical trial options while maintaining trust in the face of uncertainty.
Christopher Wallis, MD, PhD, FRCSCProstate Cancer | June 24, 2025
The panel explores the emotional weight of a cancer diagnosis and the importance of empathetic communication.
Alicia Morgans, MD, MPHCRPC | June 12, 2024
Drs. Morgans, Wallis dissect the association between PSA level of < 0.2 ng/mL and risk of radiological progression in ...
;